Insulet (PODD) Net Margin Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,992.00 |
| Sep 30, 2025 | 745.00 |
| Jun 30, 2025 | -290.00 |
| Mar 31, 2025 | 730.00 |
| Dec 31, 2024 | 1,447.00 |
| Sep 30, 2024 | 1,383.00 |
| Jun 30, 2024 | 3,782.00 |
| Mar 31, 2024 | 890.00 |
| Dec 31, 2023 | 1,428.00 |
| Sep 30, 2023 | 1,090.00 |
| Jun 30, 2023 | 825.00 |
| Mar 31, 2023 | 1,193.00 |
| Dec 31, 2021 | 890.00 |
| Sep 30, 2021 | 464.00 |
| Jun 30, 2021 | -979.00 |
| Dec 31, 2020 | 668.00 |
| Sep 30, 2020 | 628.00 |
| Jun 30, 2020 | 333.00 |
| Mar 31, 2020 | 183.00 |
| Dec 31, 2019 | 492.00 |
| Sep 30, 2019 | 1,488.00 |
| Jun 30, 2019 | 4,122.00 |
| Mar 31, 2019 | 1,164.00 |
| Dec 31, 2018 | 965.00 |
| Sep 30, 2018 | 3,594.00 |
| Jun 30, 2018 | 1,614.00 |
| Mar 31, 2018 | 1,331.00 |
| Dec 31, 2016 | 3,042.00 |
| Sep 30, 2016 | 3,034.00 |
| Jun 30, 2016 | 2,527.00 |
| Mar 31, 2016 | 3,264.00 |
| Dec 31, 2015 | 6,149.00 |
| Sep 30, 2015 | 4,621.00 |
| Jun 30, 2015 | 6,281.00 |